206 related articles for article (PubMed ID: 18624670)
1. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.
Apisarnthanarak A; Mundy LM
Infect Control Hosp Epidemiol; 2008 Jul; 29(7):678-9. PubMed ID: 18624670
[No Abstract] [Full Text] [Related]
2. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I
J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
[TBL] [Abstract][Full Text] [Related]
6. Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City.
Abdallah M; Olafisoye O; Cortes C; Urban C; Landman D; Quale J
Antimicrob Agents Chemother; 2015 Mar; 59(3):1802-5. PubMed ID: 25534744
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for multidrug-resistant nonfermenters.
Briceño DF; Quinn JP; Villegas MV
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):303-15. PubMed ID: 20192684
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of tetracyclines against different clones of multidrug-resistant Acinetobacter baumannii isolates from two Iranian hospitals.
Pajand O; Hojabri Z; Nahaei MR; Hajibonabi F; Pirzadeh T; Aghazadeh M; Fasciana T; Bonura C; Mammina C
Int J Antimicrob Agents; 2014 May; 43(5):476-8. PubMed ID: 24657045
[No Abstract] [Full Text] [Related]
9. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii.
Goff DA; Kaye KS
Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511
[No Abstract] [Full Text] [Related]
10. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
Ozbek B; Sentürk A
Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
Capone A; D'Arezzo S; Visca P; Petrosillo N;
J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
[No Abstract] [Full Text] [Related]
14. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications.
Falagas ME; Mourtzoukou EG; Polemis M; Vatopoulos AC;
Clin Microbiol Infect; 2007 Aug; 13(8):816-9. PubMed ID: 17610601
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
Seifert H; Stefanik D; Wisplinghoff H
J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
[No Abstract] [Full Text] [Related]
19. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
Schafer JJ; Goff DA; Stevenson KB; Mangino JE
Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
[TBL] [Abstract][Full Text] [Related]
20. Detection of pan drug-resistant Acinetobacter baumannii in Germany.
Göttig S; Gruber TM; Higgins PG; Wachsmuth M; Seifert H; Kempf VA
J Antimicrob Chemother; 2014 Sep; 69(9):2578-9. PubMed ID: 24833751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
